ALNY · Alnylam Pharmaceuticals, Inc. · Analyst Estimates
$165.04
+8.39 (+5.36%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$22.11B
Shares
133.94M
Volume · Nov 13
3.59M
Avg daily vol (3M)
2.04M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Alnylam Pharmaceuticals, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-15 09:16 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
21.67
|
22.68
|
24.71
|
15
|
22.61
|
8.83
|
8.85
|
8.92
|
0
|
0
|
1
|
11
|
|
Revenue
USD
Publication date not stated |
5.37B
|
5.44B
|
5.57B
|
28
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
7.28
|
10.83
|
14.23
|
17
|
11.15
|
12.42
|
12.47
|
12.59
|
1
|
11
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
5.53B
|
6.53B
|
7.95B
|
28
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
1.51
|
2.42
|
3.52
|
14
|
2.33
|
2.72
|
2.71
|
2.78
|
1
|
9
|
1
|
2
|
|
Revenue
USD
Publication date not stated |
1.45B
|
1.52B
|
1.63B
|
23
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
1.80
|
2.62
|
3.24
|
8
|
2.72
|
2.97
|
2.98
|
2.98
|
4
|
5
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
1.28B
|
1.53B
|
1.80B
|
11
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
589 filings
542 filers
Visit website
Investor relations